Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Arai · SciRah

Researcher profile · Semantic Scholar

D. Arai

Share profile

D. Arai — researcher profile on SciRah

h-index: 22
Works: 76
Citations: 1,569

Most-cited papers

Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
H. Terai, K. Soejima, H. Yasuda, Sohei Nakayama +10 more
2013Molecular Cancer Research211 citations Open access
Semantic Scholar
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer
Toshiyuki Hirano, H. Yasuda, T. Tani, Junko Hamamoto +11 more
2015OncoTarget158 citations Open access
Semantic Scholar
A second update on mapping the human genetic architecture of COVID-19
Masahiro Shea J. Mattia Christine Benjamin M. Mark Andrea G Kanai Andrews Cordioli Stevens Neale Daly Ganna Pa, Masahiro Shea J. Mattia Christine Benjamin M. Mark Andrea Kanai Andrews Cordioli Stevens Neale Daly Ganna, Masahiro Kanai, S. Andrews +496 more
2022Nature108 citations Open access
Semantic Scholar
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Y. Sakata, S. Sakata, Y. Oya, M. Tamiya +18 more
2021European Journal of Cancer87 citations
Semantic Scholar
Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer
Masayoshi Miyawaki, H. Yasuda, T. Tani, Junko Hamamoto +10 more
2016Molecular Cancer Research71 citations Open access
Semantic Scholar
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity
R. Edahiro, Y. Shirai, Yusuke Takeshima, S. Sakakibara +450 more
2023Nature Genetics58 citations Open access
Semantic Scholar
Mimicking the niche of lung epithelial stem cells and characterization of several effectors of their in vitro behavior.
A. Hegab, D. Arai, Jing-Tao Gao, Aoi Kuroda +5 more
2015Stem Cell Research58 citations Open access
Semantic Scholar
Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells
T. Tani, H. Yasuda, Junko Hamamoto, Aoi Kuroda +9 more
2015Molecular Cancer Therapeutics57 citations Open access
Semantic Scholar
Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).
G. Saito, Y. Oya, Y. Taniguchi, Hayato Kawachi +15 more
2021Lung Cancer56 citations
Semantic Scholar
Real‐world Efficacy and Safety of Nivolumab for Advanced Non–Small‐cell Lung Cancer: A Retrospective Multicenter Analysis
Keigo Kobayashi, I. Nakachi, K. Naoki, Ryosuke Satomi +14 more
2018Clinical Lung Cancer48 citations
Semantic Scholar
Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.
Keiko Ohgino, K. Soejima, H. Yasuda, Y. Hayashi +11 more
2014Lung Cancer48 citations Open access
Semantic Scholar
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations
S. Ikemura, H. Yasuda, S. Matsumoto, M. Kamada +24 more
2019Proceedings of the National Academy of Sciences of the United States of America47 citations Open access
Semantic Scholar
FOXD1 expression is associated with poor prognosis in non-small cell lung cancer.
Sohei Nakayama, K. Soejima, H. Yasuda, S. Yoda +11 more
2015Anticancer Research42 citations
Semantic Scholar
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers.
Takashi Sato, K. Soejima, D. Fujisawa, M. Takeuchi +21 more
2018The Oncologist40 citations Open access
Semantic Scholar
Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma
Makoto Nishino, M. Ozaki, A. Hegab, Junko Hamamoto +7 more
2017Journal of Cancer35 citations Open access
Semantic Scholar
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer
K. Ishioka, H. Yasuda, Junko Hamamoto, H. Terai +31 more
2021Cancer Research33 citations Open access
Semantic Scholar
Drug-related pneumonitis induced by osimertinib as first-line treatment for EGFR-positive non-small cell lung cancer: a real-world setting.
Yuki Sato, H. Sumikawa, R. Shibaki, Takeshi Morimoto +18 more
2022Chest30 citations
Semantic Scholar
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force
Qing-Bo S. Wang, R. Edahiro, H. Namkoong, Takanori Hasegawa +439 more
2022Nature Communications28 citations Open access
Semantic Scholar
Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma
D. Arai, A. Hegab, K. Soejima, Aoi Kuroda +8 more
2014Journal of Pathology25 citations Open access
Semantic Scholar
Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.
H. Terai, M. Ishii, R. Takemura, H. Namkoong +145 more
2023Respiratory Investigation24 citations Open access
Semantic Scholar
Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer
Takashi Sato, K. Soejima, Eri Arai, Junko Hamamoto +10 more
2015Oncology Report24 citations Open access
Semantic Scholar
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
A. Nakamura, O. Yamaguchi, K. Mori, Keita Miura +12 more
2023European Journal of Cancer23 citations
Semantic Scholar
Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma
Junko Hamamoto, K. Soejima, K. Naoki, H. Yasuda +11 more
2014Cancer Science21 citations Open access
Semantic Scholar
Multiple roles of extracellular fibroblast growth factors in lung cancer cells.
Takahiro Suzuki, H. Yasuda, Koji Funaishi, D. Arai +8 more
2015International Journal of Oncology20 citations Open access
Semantic Scholar
Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan
H. Namkoong, R. Edahiro, K. Fukunaga, Y. Shirai +448 more
2021medRxiv19 citations Open access
Semantic Scholar
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
M. Imaji, Daichi Fujimoto, Yuki Sato, Y. Sakata +18 more
2022European Journal of Cancer18 citations
Semantic Scholar
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study
Hayato Kawachi, M. Tamiya, Y. Taniguchi, T. Yokoyama +15 more
2022JTO Clinical and Research Reports16 citations Open access
Semantic Scholar
Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal study
Takashi Sato, D. Fujisawa, D. Arai, I. Nakachi +21 more
2021Palliative Medicine15 citations Open access
Semantic Scholar
Long‑term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR‑mutant PC9 lung cancer cell line.
H. Terai, K. Soejima, H. Yasuda, Takashi Sato +8 more
2015International Journal of Oncology15 citations Open access
Semantic Scholar
Longitudinal Assessment of Prognostic Understanding in Advanced Lung Cancer Patients and Its Association with Their Psychological Distress.
D. Arai, Takashi Sato, I. Nakachi, D. Fujisawa +17 more
2021The Oncologist14 citations Open access
Semantic Scholar
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).
Masayoshi Miyawaki, K. Naoki, S. Yoda, Sohei Nakayama +21 more
2017Molecular and clinical oncology11 citations Open access
Semantic Scholar
Real-world survey of pneumonitis/radiation pneumonitis among patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy after durvalumab approval: A multicenter retrospective cohort study (HOPE-005/CRIMSON).
G. Saito, Y. Oya, Y. Taniguchi, Hayato Kawachi +15 more
202010 citations
Semantic Scholar
Repetitive instructions at short intervals contribute to the improvement of inhalation technique
R. Baba, I. Nakachi, K. Masaki, T. Amagai +7 more
2020Asia Pacific Allergy10 citations Open access
Semantic Scholar
Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells
Keiko Ohgino, H. Terai, H. Yasuda, Shigenari Nukaga +11 more
2020Cancer Science9 citations Open access
Semantic Scholar
A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.
S. Ikemura, K. Naoki, H. Yasuda, I. Kawada +11 more
2015Japanese Journal of Clinical Oncology9 citations
Semantic Scholar
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study
Yutaku Matsubara, H. Kiyohara, Y. Mikami, K. Nanki +461 more
2024Journal of gastroenterology8 citations
Semantic Scholar
Successful Retreatment Using Pembrolizumab for Non-small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report.
Keigo Kobayashi, I. Nakachi, A. Mitsuishi, D. Arai +6 more
2019Clinical Lung Cancer7 citations
Semantic Scholar
A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
K. Soejima, K. Naoki, K. Ishioka, M. Nakamura +17 more
2015Cancer Chemotherapy and Pharmacology7 citations
Semantic Scholar
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial
Kazutaka Fujita, R. Arai, S. Shoji, R. Saito +22 more
2023Cancer Science6 citations Open access
Semantic Scholar
Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations
K. Nakagawara, A. Morita, H. Namkoong, H. Terai +39 more
2023Vaccine: X6 citations Open access
Semantic Scholar
Cardiac tamponade due to primary malignant pericardial mesothelioma diagnosed with surgical pericardial resection.
Naoki Kawakami, M. Kawai, H. Namkoong, D. Arai +7 more
2021Journal of Cardiology Cases6 citations Open access
Semantic Scholar
Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysis.
T. Fukushima, Y. Oyamada, S. Ikemura, Shigenari Nukaga +12 more
2022Clinical Lung Cancer5 citations Open access
Semantic Scholar
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Y. Minegishi, T. Akagami, M. Arai, R. Saito +21 more
2022Lung Cancer4 citations Open access
Semantic Scholar
Clinical Interpretations and Therapeutic Significance of Isolating Aspergillus Species from Respiratory Specimens
R. Baba, H. Takaoka, T. Kamo, D. Arai +6 more
20204 citations
Semantic Scholar
A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab.
K. Naoki, Y. Takeda, K. Soejima, D. Arai +6 more
2017Oncology Letters4 citations Open access
Semantic Scholar
Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case report
M. Ishii, K. Asano, N. Kamiishi, Y. Hayashi +8 more
2012Journal of Medical Case Reports4 citations Open access
Semantic Scholar
Real-World Efficacy and Safety of Atezolizumab for Advanced Non-Small Cell Lung Cancer in Japan: A Retrospective Multicenter Analysis
Masahiko Okada, Keiko Ohgino, Kohei Horiuchi, K. Sayama +12 more
2024Journal of Clinical Medicine3 citations Open access
Semantic Scholar
FOXD 1 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer
Sohei Nakayama, K. Soejima, H. Yasuda, S. Yoda +11 more
20143 citations
Semantic Scholar
Signal Transduction Activation of the FGF 2-FGFR 1 Autocrine Pathway : A Novel Mechanism of Acquired Resistance to Ge fi tinib in NSCLC
H. Terai, K. Soejima, H. Yasuda, Sohei Nakayama +10 more
20133 citations
Semantic Scholar
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer
N. Kameyama, Takashi Sato, D. Arai, D. Fujisawa +18 more
2022JCO Oncology Practice2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Soejima×31
Invite
K. Soejima — researcher profile on SciRah
H. Yasuda×29
Invite
H. Yasuda — researcher profile on SciRah
K. Ishioka×28
Invite
K. Ishioka — researcher profile on SciRah
K. Naoki×28
Invite
K. Naoki — researcher profile on SciRah

×22

Invite

T. Betsuyaku — researcher profile on SciRah

Invite

H. Terai — researcher profile on SciRah

Keiko Ohgino×21

Invite

Keiko Ohgino — researcher profile on SciRah

Invite

S. Ikemura — researcher profile on SciRah

Invite

I. Kawada — researcher profile on SciRah

Junko Hamamoto×17

Invite

Junko Hamamoto — researcher profile on SciRah

Invite

I. Nakachi — researcher profile on SciRah

Takashi Sato×14

Invite

Takashi Sato — researcher profile on SciRah